Dihydronorguaiaretic acid

Dihydronorguaiaretic acid Brand names, Dihydronorguaiaretic acid Analogs

Dihydronorguaiaretic acid Brand Names Mixture

No information avaliable

Dihydronorguaiaretic acid Chemical_Formula

C₂₂H₃₀O₃

Dihydronorguaiaretic acid RX_link

http://www.rxlist.com/cgi/generic4/megace_es.htm

Dihydronorguaiaretic acid fda sheet

Dihydronorguaiaretic_acid FDA

Dihydronorguaiaretic acid msds (material safety sheet)

Dihydronorguaiaretic_acid MSDS

Dihydronorguaiaretic acid Synthesis Reference

No information avaliable

Dihydronorguaiaretic acid Molecular Weight

342.472 g/mol

Dihydronorguaiaretic acid Melting Point

218.0-220.0^oC

Dihydronorguaiaretic acid H₂O Solubility

2 µg/mL (at 37°C for the acetate salt)

Dihydronorguaiaretic acid State

Solid

Dihydronorguaiaretic acid LogP

3.123

Dihydronorguaiaretic acid Dosage Forms

Oral suspension containing 125 mg of megestrol acetate per mL; Tablet

Dihydronorguaiaretic acid Indication

For the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS). Also used to treat breast cancer, endometrial cancer, and prostate cancer in Canada and some other countries.

Dihydronorguaiaretic acid Pharmacology

Megestrol is a synthetic progestin and has the same physiologic effects as natural progesterone. The precise mechanism of megestrol’s antianorexic and anticachetic effects is unknown. Initially developed as a contraceptive, it was first evaluated in breast cancer treatment in 1967.

Dihydronorguaiaretic acid Absorption

Variable, but well absorbed orally.

Dihydronorguaiaretic acid side effects and Toxicity

No serious unexpected side effects have resulted from studies involving megestrol acetate oral suspension administered in dosages as high as 1200 mg/day.

Dihydronorguaiaretic acid Patient Information